Sharemaestro Newsreel

Labcorp Announces FDA Approval of Companion Diagnostic Supporting Patients with Advanced Melanoma

Labcorp (NYSE: LH) has announced that the FDA approved its PGDx elio® tissue complete CDx as a companion diagnostic. This diagnostic tool helps identify patients with advanced melanoma who have specific BRAF variants, making them eligible for targeted BRAF and BRAF/MEK inhibitor therapies. This …

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. : TD COWEN RAISES TARGET PRICE TO $300 FROM $235

TD Cowen has increased its target price for Charles River Laboratories International, Inc. (CRL.N) to $300 from $235. This update reflects a change in the analyst's outlook for the company's stock. The article is a brief news alert from Reuters regarding this financial analyst …

For advanced melanoma, Labcorp's test supports access to targeted therapies

Labcorp announced that the FDA has approved its PGDx elio® tissue complete CDx as a companion diagnostic for advanced melanoma. This test identifies specific BRAF V600E/K variants, allowing clinicians to determine which patients may benefit from targeted BRAF and BRAF/MEK inhibitor therapies. The kit-based …

Canaccord raises Biodesix stock price target on strong test volume

Canaccord has increased its price target for Biodesix Inc. (NASDAQ:BDSX) to $35 from $27, maintaining a Buy rating, due to higher revenue projections for 2026 and beyond. This adjustment follows Biodesix's strong second-quarter 2026 results, which surpassed estimates, driven by increased Nodify test volume …

Entera Q2 Loss Widens, FDA Backs EB613 For Phase 3 Osteoporosis Trial, Expects Data In Q2 Of FY28

(RTTNews) - Entera Bio Ltd. (ENTX), a clinical-stage biopharmaceutical company, reported a wider net loss for the second quarter, on surge in financial expense and more than double the growth in research and development expenses. Further, the company plans to initiate Phase 3 study …

Check-Cap executes 1-for-7 reverse stock split, shares trade split-adjusted Aug. 12

Check-Cap has announced a 1-for-7 reverse stock split for its ordinary shares, effective August 12, 2026. The shares will continue to trade on Nasdaq under the ticker MBAI on a split-adjusted basis, and the number of issued shares is expected to decrease significantly. Fractional …

The Manufacturers Life Insurance Company Cuts Position in RadNet, Inc. $RDNT

The Manufacturers Life Insurance Company reduced its stake in RadNet, Inc. (NASDAQ:RDNT) by 35% in the first quarter, selling 18,543 shares and retaining 34,460 shares valued at $1.93 million. Despite a consensus "Moderate Buy" rating, analyst sentiment is mixed, with some downgrades and price …

NewEdge Advisors LLC Acquires 5,761 Shares of IDEXX Laboratories, Inc. $IDXX

NewEdge Advisors LLC increased its stake in IDEXX Laboratories, Inc. by 60.9% in the first quarter, purchasing an additional 5,761 shares, bringing their total holdings to 15,221 shares valued at $8.55 million. The company reported strong Q1 earnings with EPS of $4.27, beating estimates, …

RadNet earnings beat by $0.09, revenue topped estimates

RadNet (NASDAQ: RDNT) announced second-quarter earnings per share of $0.29, surpassing analyst estimates by $0.09, and revenue of $622.7 million, exceeding the consensus of $610.01 million. The company projects FY 2026 revenue between $2.37 billion and $2.42 billion, below the analyst consensus of $2.49 …

US Stock Market Today: S&P 500 Futures Climb On Softer Jobs Data And Yields

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. The Morning Bull - US Market Morning Update Monday, Aug, 10 2026 US stock futures are pointing higher this morning, with the S&P …

Fulgent Genetics, Inc. $FLGT Shares Sold by Dimensional Fund Advisors LP

Dimensional Fund Advisors LP significantly reduced its stake in Fulgent Genetics (NASDAQ:FLGT) by 24.4% in the first quarter, selling over 217,000 shares. This comes as Fulgent Genetics reported a quarterly loss and revenue below analyst expectations, contributing to a "Hold" consensus rating among analysts. …

Thermo Fisher eyes 15%-20% India customer growth on biopharma research, manufacturing boost

Thermo Fisher Scientific is targeting a 15%-20% increase in its customer base in India over the next five years, driven by the expanding biopharma research and manufacturing sectors. The U.S.-based company, which produces lab and drug development equipment, expects continued double-digit growth in India, …

Price to sales forward of Burning Rock Biotech Ltd. Sponsored ADR – FWB:6BU0

This article provides financial information for Burning Rock Biotech Ltd. Sponsored ADR (FWB:6BU0) on TradingView. It specifies the "Price to sales forward" metric for the company, indicating the data was made by humans. The content primarily focuses on navigation and platform features rather than …

Assenagon Asset Management S.A. Grows Holdings in Illumina, Inc. $ILMN

Assenagon Asset Management S.A. significantly increased its stake in Illumina, Inc. (NASDAQ:ILMN) by 188.6% in the second quarter, now holding 140,003 shares valued at approximately $24.6 million. This comes as Illumina exceeded quarterly earnings and revenue expectations and maintained its fiscal 2026 EPS guidance. …

Assenagon Asset Management S.A. Increases Stake in Labcorp Holdings Inc. $LH

Assenagon Asset Management S.A. significantly increased its stake in Labcorp Holdings Inc. (NYSE:LH) by 22.8% in the second quarter, now holding 69,305 shares valued at $19.4 million. This move is part of a broader trend of institutional investors, who collectively own 95.94% of the …

Qiagen NV (QGEN) Earnings Forecast: Future EPS & Revenue Growth Estimates

RadNet: Q2 Earnings Snapshot

The article provides a Q2 earnings snapshot for RadNet. However, the full content of the snapshot is not available in the provided text.

Sotera Health (SHC) Is Getting Attention Again, What Is Behind It?

Sotera Health (SHC) has gained renewed attention following its Q2 2026 earnings, reporting increased revenue and net income. The stock has shown strong recent performance, with a 22.23% 90-day return and a 35.00% one-year return. Analysts have a consensus price target of $20.22, suggesting …

RadNet Non-GAAP EPS of $0.29, revenue of $622.7M; updates FY2026 outlook

* RadNet press release [https://seekingalpha.com/pr/20612360-radnet-reports-second-quarter-financial-results-with-record-quarterly-revenue-and-adjusted] (RDNT [https://seekingalpha.com/symbol/RDNT]): Q2 Non-GAAP EPS of $0.29. * Revenue of $622.7M (+25.0% Y/Y). * _Total Company Adjusted EBITDA__(__1)_ _was a quarterly record of $99.7 million in the second quarter of 2026 as compared with $81.2 million in the second …

Sotera Health (SHC) Stock Trails Profit Surge As Legal Risks Linger

Sotera Health (SHC) recently reported strong Q2 2026 earnings, with significant increases in revenue and net income, yet its stock price barely moved due to lingering legal risks, heavy capital spending, and past insider selling. The company's operating performance, particularly in its sterilization and …

IVY LANE CAPITAL MANAGEMENT, LLC's Quest Diagnostics Inc(DGX) Holding History

This article details IVY LANE CAPITAL MANAGEMENT, LLC's historical holdings in Quest Diagnostics Inc (DGX). As of March 31, 2026, the firm holds 29,000 shares valued at $5.68 million, representing 8.59% of its portfolio. The investment has generated an estimated gain of $4.19 million, …

Twist Bioscience (TWST) Is Up 26.3% After Equity Raise And Guidance Hike Has The Bull Case Changed?

In early August 2026, Twist Bioscience completed a US$300 million follow-on common stock offering at US$96 per share after raising its fiscal 2026 revenue guidance to US$456 million–US$457 million and reporting third-quarter sales of US$118.38 million despite a net loss of US$35.05 million. Alongside …

Is RadNet (RDNT) Undervalued As AI Growth Hopes Push The Stock Higher?

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Recent trading action and performance snapshot RadNet (RDNT) has drawn investor attention after recent trading, with the stock closing at US$72.39 on 4 August …

Thermo Fisher (TMO) vs Danaher (DHR): Which Life Sciences Stock Looks Better Positioned?

Thermo Fisher Scientific Inc. (NYSE:TMO) and Danaher Corporation (NYSE:DHR) are two of the world's largest life sciences tools companies, making them natural competitors for investors looking to capitalize on a recovery in pharmaceutical and biotechnology research spending. Both companies delivered better-than-expected second-quarter results, but …

HF Advisory Group LLC Acquires New Position in Thermo Fisher Scientific Inc. $TMO

HF Advisory Group LLC has acquired a new position in Thermo Fisher Scientific Inc. (NYSE:TMO), purchasing 2,466 shares valued at approximately $1.24 million in the second quarter. Other institutional investors also increased their stakes in the company, bringing total institutional ownership to 89.23%. Analysts …

Legacy Wealth Management LLC MS Sells 8,935 Shares of IQVIA Holdings Inc. $IQV

Legacy Wealth Management LLC MS reduced its stake in IQVIA Holdings Inc. (NYSE:IQV) by 53.5% in the second quarter, selling 8,935 shares and retaining 7,752 shares valued at approximately $1.5 million. Despite this, IQVIA reported strong Q2 earnings, beating analyst estimates with $3.15 EPS …

Adlai Nortye Ltd (ANL) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Adlai Nortye Ltd (ANL), highlighting that analysts predict a "Buy" trend based on the ratings of 6 analysts. The target price for ANL is forecasted at USD 28.600, representing a significant upside potential. However, it notes that …

Jacobs & Co. CA Raises Position in Waters Corporation $WAT

Jacobs & Co. CA increased its stake in Waters Corporation (NYSE:WAT) by 22.6% in the second quarter, bringing its total holdings to 15,518 shares valued at $5.8 million. Waters reported strong Q2 earnings and revenue, exceeding analyst estimates, and maintained its full-year EPS guidance. …

Here are the major earnings before the open Monday

Major earnings expected before the bell on Monday include: * Barrick Mining Corporation (B [https://seekingalpha.com/symbol/B]) * Medical Properties Trust (MPT [https://seekingalpha.com/symbol/MPT]) * Seadrill Limited (SDRL [https://seekingalpha.com/symbol/SDRL]) * monday.com Ltd. (MNDY [https://seekingalpha.com/symbol/MNDY]) * Village Farms International (VFF [https://seekingalpha.com/symbol/VFF]) Other earnings slated for release before Monday's …

Should ICON’s Anthropic AI Collaboration Amid Weaker Q2 Profitability Require Action From ICON (ICLR) Investors?

ICON plc reported weaker Q2 2026 net income despite slightly higher sales, reaffirming full-year revenue guidance. Concurrently, ICON announced a multi-year collaboration with Anthropic to integrate Claude's AI into its clinical trial workflows, aiming to enhance protocol optimization and real-time monitoring. While this AI …

Insight Molecular Diagnostics Q2 2026 Earnings Preview

* Insight Molecular Diagnostics Inc. (IMDX [https://seekingalpha.com/symbol/IMDX]) is scheduled to announce Q2 earnings results on Monday, August 10th, after market close. * The consensus EPS estimate is -$0.25, [https://seekingalpha.com/symbol/IMDX/earnings/estimates] and the consensus revenue estimate is $0.44M * Over the last year, IMDX has beaten …

3 Stocks Under $50 with Open Questions

3 Stocks Under $50 with Open Questions Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges. However, investors should remain vigilant as some may still have unproven business models, leaving them vulnerable …

RadNet beats Q2 estimates, raises outlook as imaging demand surges

[Mid adult nurse during magnetic resonance exam at hospital] FG Trade Latin/E+ via Getty Images RadNet (RDNT [https://seekingalpha.com/symbol/RDNT]) on Sunday reported second-quarter revenue and earnings that topped Wall Street expectations as demand for advanced diagnostic imaging surged and its Digital Health business continued to …

Press Release: RadNet Reports Second Quarter Financial Results With Record Quarterly Revenue and Adjusted EBITDA(1) and Revises Upwards 2026 Financial Guidance Ranges

RadNet announced record second-quarter financial results with revenue of $428.1 million and Adjusted EBITDA of $75.5 million. The company also raised its 2026 financial guidance ranges due to the strong performance and the anticipated benefits from its continued growth and strategic initiatives. This positive …

RadNet Reports Record Second Quarter 2026 Revenue and Adjusted EBITDA, Raises Full-Year Imaging Center Guidance

RadNet, Inc. reported record financial results for the second quarter of 2026, with total revenue increasing 25% to $622.7 million and Adjusted EBITDA rising 22.7% to $99.7 million. The Digital Health segment showed substantial growth with a 56.5% revenue increase and nearly 97% surge …

BRIEF-RadNet Q2 EPS USD 0.1

RadNet reported its Q2 Earnings Per Share (EPS) as USD 0.1. The brief note from Refinitiv was published on TradingView News. To access the full article and more news, a subscription or further access might be required.